Hudson Bay Capital Management
NUVB icon

Hudson Bay Capital Management’s Nuvation Bio NUVB Stock Holding History

Hudson Bay Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,070
Closed -$108K – 1580
2026
Q1 		$108K Buy
+25,070
New +$140K ﹤0.01% 1175
2022
Q1 		– Sell
-500,000
Closed -$4.25M – 1276
2021
Q4 		$4.25M Hold
500,000
– – 0.04% 401
2021
Q3 		$4.97M Sell
500,000
-704
-0.1% -$6.38K 0.07% 329
2021
Q2 		$4.66M Sell
500,704
-679,630
-58% -$7.75M 0.06% 377
2021
Q1 		$12.3M Buy
1,180,334
+992,399
+528% +$11.1M 0.15% 92
2020
Q4 		$2.2M Buy
+187,935
New +$1.95M 0.02% 355

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Hudson Bay Capital Management's NUVB Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 25,070 shares — an estimated $108K sold.

Hudson Bay Capital Management first reported a position in NUVB in Q4 2020 and held it in 6 quarters. The position peaked at $12.3M in Q1 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 25,070 Nuvation Bio shares in Q2 2026, an estimated $108K.
  • Hudson Bay Capital Management first reported a position in Nuvation Bio in Q4 2020 and held it in 6 quarters.
  • Hudson Bay Capital Management's Nuvation Bio position peaked at $12.3M in Q1 2021.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.